Latest News and Press Releases
Want to stay updated on the latest news?
-
Partene ble enige om en selskapsverdi på 33 millioner Euro, noe som resulterte i en kjøpspris på 22,94 millioner Euro, regulert for gjeld. Det tilsvarer om lag 190 millioner norske kroner. - Gjennom...
-
SAN FRANCISCO, March 5, 2001 (PRIMEZONE) -- On Tuesday, March 6, 2001, StreetFusion, the online network for financial events, will webcast quarterly earnings calls for the companies listed below. ...
-
PhotoCure ASA has recently completed a phase III clinical trial in USA with Metvix® where more than 400 pre-cancerous skin lesions caused by sun damage (actinic keratosis (AK) or “sun spots”) were...
-
PhotoCure ASA har nylig avsluttet en fase III studie i USA med Metvix®, der mer enn 400 lesjoner med premaligne hudforandringer forårsaket av solskade (aktinisk keratose, AK), har blitt behandlet....
-
OKLAHOMA CITY, March 4, 2001 (PRIMEZONE) -- Dobson Communications Corporation (Nasdaq:DCEL) today announced that accelerating demand for digital services resulted in record growth in the quarter...
-
OKLAHOMA CITY, March 4, 2001 (PRIMEZONE) -- Dobson Communications Corporation (Nasdaq:DCEL) today announced that American Cellular Corporation, which is owned by a joint venture equally owned by...
-
PHILADELPHIA, March 3, 2001 (PRIMEZONE) -- The law firm of Berger & Montague, P.C. (http://www.investorprotect.com) filed a class action in the United States District Court for the Northern District...
-
GRAND RAPIDS, Mich., March 2, 2001 (PRIMEZONE) -- Welcome Homes, Michigan's only retirement community for the visually impaired, is proud to bring Ray Charles to DeVos Hall in Grand Rapids, on...
-
FAIRFIELD, Conn., March 2, 2001 (PRIMEZONE) -- Competitive Technologies, Inc. (AMEX:CTT) today announced that its licensee, Ribozyme Pharmaceuticals, Inc. (Nasdaq:RZYM), yesterday submitted an...
-
BALTIMORE, March 2, 2001 (PRIMEZONE) -- Law Offices Of Charles J. Piven, P.A. today announced that private securities actions requesting class action status have been initiated on behalf of...